Literature DB >> 28303446

Expression of human cytomegalovirus components in the brain tissues of patients with Rasmussen's encephalitis.

Yao Zhang1, Yisong Wang2, Sichang Chen1, Shuai Chen1, Yuguang Guan1, Changqing Liu1, Tianfu Li3, Guoming Luan4,5,6, Jing An7,8.   

Abstract

Rasmussen's encephalitis (RE) is a rare and severe progressive epileptic syndrome with unknown etiology. Infection by viruses, including human cytomegalovirus (HCMV), has been speculated to be a potential trigger for RE. However, no viral antigens have been detected in the brains of patients with RE; thus, a possible clinical linkage between viral infections and RE has not been firmly established. In this study, we evaluated the expression of HCMV pp65 antigen in brain sections from 26 patients with RE and 20 non-RE patients by immunohistochemistry and in situ hybridization, and assessed the associations between HCMV infection and clinical parameters. Elevated expression of HCMV pp65 protein and DNA was observed in 88.5% (23/26) and 69.2% (18/26) of RE cases, respectively. In the non-RE group, HCMV pp65 antigen was detected only in two cases (10%), both of which were negative for DNA staining. Additionally, the intensity of HCMV pp65 staining was correlated with a shorter duration of the prodromal stage, younger age of seizure onset, and more severe unilateral cortical atrophy. Elevated expression of HCMV pp65 was observed in RE brain tissue and was correlated with the clinical features of RE disease. In summary, our results suggested that HCMV infection may be involved in the occurrence and progression of RE disease. Thus, further studies are needed to determine whether early treatment with anti-HCMV antibodies could modulate the course of RE.

Entities:  

Keywords:  Rasmussen’s encephalitis; epilepsy; human cytomegalovirus (HCMV); pp65

Mesh:

Substances:

Year:  2017        PMID: 28303446      PMCID: PMC6702243          DOI: 10.1007/s12250-016-3917-z

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  26 in total

1.  Focal seizures due to chronic localized encephalitis.

Authors:  T RASMUSSEN; J OLSZEWSKI; D LLOYDSMITH
Journal:  Neurology       Date:  1958-06       Impact factor: 9.910

2.  Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen.

Authors:  Y Li; A Uccelli; K D Laxer; M C Jeong; H V Vinters; W W Tourtellotte; S L Hauser; J R Oksenberg
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

3.  Surgical treatment of patients with Rasmussen encephalitis.

Authors:  Yuguang Guan; Jian Zhou; Guoming Luan; Xingzhou Liu
Journal:  Stereotact Funct Neurosurg       Date:  2014-02-06       Impact factor: 1.875

Review 4.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

Review 5.  Viral and host control of cytomegalovirus maturation.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  Trends Microbiol       Date:  2012-05-23       Impact factor: 17.079

6.  "Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.

Authors:  Doron Merkler; Edit Horvath; Wolfgang Bruck; Rolf M Zinkernagel; Juan Carlos Del la Torre; Daniel D Pinschewer
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

7.  CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery.

Authors:  Nicholas Schwab; Christian G Bien; Anne Waschbisch; Albert Becker; Giles H Vince; Klaus Dornmair; Heinz Wiendl
Journal:  Brain       Date:  2009-01-29       Impact factor: 13.501

8.  Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.

Authors:  S W Rogers; P I Andrews; L C Gahring; T Whisenand; K Cauley; B Crain; T E Hughes; S F Heinemann; J O McNamara
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

9.  Rasmussen's syndrome: a study of potential viral etiology.

Authors:  M R Atkins; W Terrell; C M Hulette
Journal:  Clin Neuropathol       Date:  1995 Jan-Feb       Impact factor: 1.368

10.  Upregulation of adenosine kinase in Rasmussen encephalitis.

Authors:  Guoming Luan; Qing Gao; Yuguang Guan; Feng Zhai; Jian Zhou; Changqing Liu; Yin Chen; Kun Yao; Xueling Qi; Tianfu Li
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

View more
  3 in total

1.  Elevated expression of EBV and TLRs in the brain is associated with Rasmussen's encephalitis.

Authors:  Xin Wang; Yisong Wang; Dong Liu; Peigang Wang; Dongying Fan; Yuguang Guan; Tianfu Li; Guoming Luan; Jing An
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

2.  Detection of EBV and HHV6 in the Brain Tissue of Patients with Rasmussen's Encephalitis.

Authors:  Dong Liu; Xin Wang; Yisong Wang; Peigang Wang; Dongying Fan; Sichang Chen; Yuguang Guan; Tianfu Li; Jing An; Guoming Luan
Journal:  Virol Sin       Date:  2018-10-29       Impact factor: 4.327

3.  Rasmussen's encephalitis is characterized by relatively lower production of IFN-β and activated cytotoxic T cell upon herpes viruses infection.

Authors:  Yi-Song Wang; Dong Liu; Xin Wang; Qiao-Li Luo; Ling Ding; Dong-Ying Fan; Qi-Liang Cai; Chong-Yang Tang; Wei Yang; Yu-Guang Guan; Tian-Fu Li; Pei-Gang Wang; Guo-Ming Luan; Jing An
Journal:  J Neuroinflammation       Date:  2022-03-26       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.